Molecular Microbiologist - Allschwil, Schweiz - Basilea Pharmaceutica International

Basilea Pharmaceutica International
Basilea Pharmaceutica International
Geprüftes Unternehmen
Allschwil, Schweiz

vor 4 Wochen

Lena Schneider

Geschrieben von:

Lena Schneider

beBee Recruiter
Beschreibung

We are looking for
:

....a highly motivated

Molecular Microbiologist for our

Research department


Your tasks:


  • Mode of action studies using genetic engineering of bacterial / fungal strains
  • Development and implementation of cellbased assays for efficient profiling
of new antibiotics and antifungals

  • Target validation studies
  • Profiling of novel compounds, analysis of results
  • Contribute to the expansion of Basilea antiinfectives pipeline through project proposals
  • Independently drive own projects to defined milestones
  • Responsible for the maintenance and running of a biology lab
  • Manage external collaborations
  • Documentation of data in Basilea lab notebooks and preparation of method and data summaries
  • Present results in group meetings and externally

Your profile:


  • PhD in microbiology/molecular biology/genetics with an emphasis on the use of genetics to dissect biological phenomena
  • Familiar with stateoftheart technology for genetic engineering of bacteria and/or fungi
  • Experience in the fields of antibacterials and antifungals, preferably in industry
  • Experience in antiinfective drug discovery is a plus
  • Ability to work both independently and collaboratively, wellorganized and structured with excellent analytical skills
  • Ability to stay focused and to work according to priorities
  • Good communication and presentation skills
  • Fluency in English is essential, German would be beneficial

About us:

Basilea is a revenue-generating, commercial-stage Swiss biopharmaceutical company. Our activities are focused in the areas of hospital antibiotics and hospital antifungals. Our portfolio comprises of two marketed anti-infective brands (Cresemba and Zevtera) and several preclinical anti-infective assets.

We are building on our potential for sustainable growth and valuation generation, based on increasing revenues and selective investments into internal and external innovation.

Basilea was founded in 2000 and is located in the life sciences hub of the Basel area. Basilea has about 150 employees. Since 2004, Basilea is listed on the SIX Swiss Stock Exchange with the ticker symbol BSLN.
Mehr Jobs von Basilea Pharmaceutica International
Alle Jobs von Basilea Pharmaceutica International anzeigen